BCL2 and breast carcinoma: Surprisingly, some of the compounds identified in the extract exhibited structural features that showed structural properties that predisposed them to possible interaction with the Bcl-2 receptor, which is overexpressed on cells of the breast cancer subtype called Bcl-2-enriched breast cancer [69].